slotkoers
Andere beurzen
|
||
- USD | - |
17:08 | Voorzitter Senaatscommissie Financiën stelt belastingpraktijken Pfizer in vraag | MT |
20/05 | PFIZER, INC. : DA Davidson herhaalt koopadvies voor het aandeel | ZM |
Omzet 2024 * | 60,41 mld. 55,66 mld. | Omzet 2025 * | 62,7 mld. 57,78 mld. | Marktkapitalisatie | 162 mld. 149 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 7,78 mld. 7,16 mld. | Nettowinst (verlies) 2025 * | 11,29 mld. 10,4 mld. | EV/omzet 2024 * | 3,64 x |
Nettoschuld 2024 * | 58,11 mld. 53,55 mld. | Nettoschuld 2025 * | 49,97 mld. 46,04 mld. | EV/omzet 2025 * | 3,38 x |
K/w-verhouding 2024 * |
19,8
x | K/w-verhouding 2025 * |
13,9
x | Werknemers | - |
Dividendrendement 2024 * |
5,92% | Dividendrendement 2025 * |
6,04% | Vrij verhandelbaar | 59,05% |
Recentste transcriptie over Pfizer Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 01-01-93 |
David Denton
DFI | Director of Finance/CFO | 59 | 02-05-22 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 01-07-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 66 | 01-04-20 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 23-02-17 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 27-09-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,77% | 705 mld. | |
+32,82% | 583 mld. | |
-3,60% | 364 mld. | |
+20,35% | 332 mld. | |
+5,30% | 291 mld. | |
+16,64% | 238 mld. | |
-4,13% | 210 mld. | |
+10,63% | 209 mld. | |
+8,60% | 169 mld. |